Registro:

Referencias:

• A1 Zaid, S.K., Turkson, J., Stat3 as a target for inducing apoptosis in solid and hematological tumors (2008) Cell Res, 18, pp. 254-267
• Altomare, D.A., Testa, J.R., Perturbations of the akt signaling pathway in human cancer (2005) Oncogene, 24, pp. 7455-7464
• Budihardjo, I., Oliver, H., Lutter, M., Luo, X., Wang, X., Biochemical pathways of caspase activation during apoptosis (1999) Annu. Rev. Cell Dev. Biol, 15, pp. 269-290
• Cabado, A.G., Leira, F., Vieytes, M.R., Vieites, J.M., Botana, L.M., Cytoskeletal disruption is the key factor that triggers apoptosis in okadaic acid-treated neuroblastoma cells (2004) Arch. Toxicol, 78, pp. 74-85
• Call, J.A., Eckhardt, S.G., Camidge, D.R., Targeted manipulation of apoptosis in cancer treatment (2008) Lancet Oncol, 9, pp. 1002-1011
• Cardone, M.H., Roy, N., Stennicke, H.R., Salvesen, G.S., Franke, T.F., Regulation of cell death protease caspase-9 by phosphorylation (1998) Science, 282, pp. 1318-1321
• Chan, K.T., Li, K., Liu, S.L., Chu, K.H., Toh, M., Xie, W.D., Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562 (2010) Cancer Lett, 289, pp. 46-52
• Chen, J.C., Chiu, M.H., Nie, R.L., Cordell, G.A., Qiu, S.X., Cucurbitacins and cucurbitane glycosides: Structures and biological activities (2005) Nat. Prod. Rep, 22, pp. 386-399
• Chen, W., Leiter, A., Yin, D., Meiring, M., Louw, V.J., Koeffler, H.P., Cucurbitacin B inhibits growth, arrests the cell cycle and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines (2010) Int. J. Oncol, 37, pp. 737-743
• Dong, Y., Lu, B., Zhang, X., Zhang, J., Lai, L., Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway (2010) Carcinogenesis, 31, pp. 2097-2104
• Duncan, K.L., Duncan, M.D., Alley, M.C., Sausville, E.A., Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells (1996) Biochem Pharmacol, 52, pp. 1553-1560
• Fletcher, S., Drewry, J.A., Shahani, V.M., Page, B.D.G., Gunning, P.T., Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein. Biochem (2009) Cell Biol, 87, pp. 825-833
• Han, S.W., Roman, J., Targeting apoptotic signaling pathways in human lung cancer (2010) Curr. Cancer Drug Targets, 10, pp. 566-574
• Haritunians, T., Gueller, S., Zhang, L., Badr, R., Yin, D., Cucurbitacin B induces differentiation, cell cycle arrest, acnd actin cytoskeletal alterations in myeloid leukemia cells (2008) Leuk. Res, 32, pp. 1366-1373
• Hengartner, M.O., The biochemistry of apoptosis (2000) Nature, 407, pp. 770-776
• Hsu, H.S., Huang, P.I., Chang, Y.L., Tzao, C., Chen, Y.W., Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells (2011) Cancer, 117, pp. 2970-2985
• Indran, I.R., Tufo, G., Pervaiz, S., Brenner, C., Recent advances in apoptosis, mitochondria and drug resistance in cancer cells (2011) Biochimica Biophysica Acta, 1807, pp. 735-745
• Ishdorj, G., Johnston, J.B., Gibson, S.B., Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B Leukemic Cells (2011) BMC Cancer, 11. , 10.1186/1471-2407-11-268
• Jayaprakasam, B., Seeram, N.P., Nair, M.G., Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana (2003) Cancer Lett, 10, pp. 11-16
• Kim, P.K., Park, S.Y., Koty, P.P., Hua, Y., Luketich, J.D., Billiar, T.R., Fas associating death doman protein over expression induces apoptosis in lung cancer cells (2003) J. Thorac. Cardiovasc. Surg, 125, pp. 1336-1342
• Lang, K.L., Silva, I.T., Zimmermann, L.A., Machado, V.R., Teixeira, M.R., Synthesis and cytotoxic activity evaluation of dihydrocucurbitacin B and cucurbitacin B derivatives (2012) Bioorg. Med. Chem, 20, pp. 3016-3030
• Lang, K.L., da Rosa, G.T., Rocha, M.V., Zimmermann, L.A., Silva, I.T., New cytotoxic cucurbitacins from Wilbrandia ebracteata Cogn (2011) Planta Medica, 77, pp. 1648-1651
• Lee, D.H., Iwanski, G.B., Thoennissen, N.H., Cucurbitacin: Ancient compound shedding new light on cancer treatment (2010) ScientificWorldJournal, 10, pp. 413-418
• Lee, K.W., Bode, A.M., Dong, Z., Molecular targets of phytochemicals for cancer prevention (2011) Nat. Rev. Cancer, 11, pp. 211-218
• Lessene, G., Czabotar, P.E., Colman, P.M., BCL-2 family antagonists for cancer therapy (2008) Nat. Rev. Drug Discov, 7, pp. 989-1000
• Lewis, W.H., Elvin-Lewis, M.P.F., (1977) Medical Botany: Plants Affecting Man's Health. John Wiley and Sons, p. 515. , New York, Pages
• Li, Y., Wang, R., Ma, E., Deng, Y., Wang, X., Xiao, J., Jing, Y., The induction of g2/m cell-cycle arrest and apoptosis by cucurbitacin e is associated with increased phosphorylation of eif2alpha in leukemia cells (2010) Anticancer Drugs, 21, pp. 389-400
• Liang, Y.L., Wang, L.Y., Wu, H., Ma, D.Z., Xu, Z., Zha, X.L., PKB phosphorylation and survivin expression are cooperatively regulated by disruption of microfilament cytoskeleton (2003) Mol. Cell. Biochem, 254, pp. 257-263
• Liu, T., Peng, H., Zhang, M., Deng, Y., Wu, Z., Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin (2010) Eur. J. Pharmacol, 641, pp. 15-22
• Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays (1983) J. Immunol. Methods, 65, pp. 55-63
• Nicholson, D.W., From bench to clinic with apoptosis-based therapeutic agents (2000) Nature, 407, pp. 810-816
• Radisavljevic, Z., AKT as locus of fragility in robust cancer system (2008) J. Cell. Biochem, 104, pp. 2071-2077
• Rios, J.L., Andujar, I., Escandell, J.M., Giner, R.M., Recio, M.C., Cucurbitacins as inducers of cell death and a rich source of potential anticancer compounds (2012) Curr. Pharm. Des, 18, pp. 1663-1676
• Russo, A., Terrasi, M., Agnese, V., Santini, D., Bazan, V., Apoptosis: A relevant tool for anticancer therapy (2006) Ann. Oncol, 17, pp. viill5-viil23
• Sayers, T.J., Targeting the extrinsic apoptosis signaling pathway for cancer therapy (2011) Cancer Immunol Immunother, 60, pp. 1173-1180
• Shukla, Y., Singh, R., Resveratrol and cellular mechanisms of cancer prevention (2011) Ann. N. Y. Acad. Sci, 1215, pp. 1-8
• Siegel, R., Ward, E., Brawley, O., Jemal, A., Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths (2011) CA Cancer J. Clm, 61, pp. 212-236
• Siqueira, J.M., Gazola, A.C., Farias, M.R., Volkov, L., Rivard, N., de Brum-Fernandes, A.J., Ribeiro-do-Valle, R.M., Evaluation of the antitumoral effect of dihydrocucurbitacin-B in both in vitro and in vivo models (2009) Cancer Chemother. Pharmacol, 64, pp. 529-538
• Su, Y., Li, G., Zhang, X., Gu, J., Zhang, C., Tian, Z., Zhang, J., Jsi-124 inhibits glioblastoma multiforme cell proliferation through g(2)/m cell cycle arrest and apoptosis augment (2008) Cancer Biol. Ther, 7, pp. 1243-1249
• Sun, C., Zhang, M., Shan, X., Zhou, X., Yang, J., Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling (2010) J. Cancer Res. Clin. Oncol, 136, pp. 603-610
• Sun, J., Blaskovich, M.A., Jove, R., Livingston, S.K., Coppola, D., Sebti, S.M., Cucurbitacin Q: A selective STAT3 activation inhibitor with potent antitumor activity (2005) Oncogene, 24, pp. 3236-3245
• Tan, T.T., White, E., Therapeutic targeting of death pathways in cancer: Mechanisms for activating cell death in cancer cells (2008) Adv. Exp. Med. Biol, 615, pp. 81-104
• Tannin-Spitz, T., Grossman, S., Dovrat, S., Gottlieb, H.E., Bergman, M., Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells (2007) Biochem. Pharmacol, 73, pp. 56-67
• Thoennissen, N.H., Iwanski, G.B., Doan, N.B., Okamoto, R., Lin, P., Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells (2009) Cancer Res, 69, pp. 5876-5884
• van Genderen, H., Kenis, H., Lux, P., Ungeth, L., Maassen, C., In vitro measurement of cell death with the annexin A5 affinity assay (2006) Nat. Protoc, 1, pp. 363-367
• Wakimoto, N., Yin, D., O'Kelly, J., Haritunians, T., Karlan, B., Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo (2008) Cancer Sci, 99, pp. 1793-1797
• Yasuda, S., Yogosawa, S., Izutani, Y., Nakamura, Y., Watanabe, H., Sakai, T., Cucurbitacin B induces G2 arrest and apoptosis via a reactive oxygen species-dependent mechanism in human colon adenocarcinoma SW480 cells (2010) Mol. Nutr Food Res, 54, pp. 559-565
• Yin, D., Wakimoto, N., Xing, H., Lu, D., Huynh, T., Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme (2008) Int. J. Cancer, 123, pp. 1364-1375
• Yu, H., Jove, R., The STATs of cancer: New molecular targets come of age (2004) Nat. Rev. Cancer, 4, pp. 97-105
• Zhang, M., Sun, C., Shan, X., Yang, X., Li-Ling, J., Deng, Y., Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling (2010) Pancreas, 39, pp. 923-929

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------